’India will become free from NTDs by 2020’
India is in a position to elevate Neglected Tropical Diseases (NTDs) and build awareness on how their control and elimination will…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Strides Arcolab completes sale of Agila Specialties division to Mylan
$250 million to be payable upon satisfaction of certain regulatory conditions
UK partners with BioAsia as principal country partner
Partners with BioAsia as principal country partner
Jubilant Life Sciences receives ANDA approval for Quetiapine Fumarate tablets
Is indicated for the treatment of schizophrenia, and for the treatment of acute manic episodes associated with bipolar disorder
Venus Remedies signs MoU for Elores with South African pharmaceutical firm
Expects to generate a cumulative revenue of $20 million within five years of the launch
EMA approves new tuberculosis drug delamanid
Otsuka’s phase III clinical trials for delamanid are now underway
Lilly enters branded generics market with launch of Lil Therapeutics
Announces launch of drugs in breast cancer and colo-rectal cancer segment
Cadila Pharmaceuticals and UK’s Helperby Therapeutics in pact
Helperby will supply Cadila Pharmaceuticals with antibiotic resistance breakers
… launches ’Mycidac-C’
The drug is a first in the class active immunotherapy as well as drug targeting Desmocollin-3